The problem of medicating women like the men: Conceptual discussion of menstrual cycle-dependent psychopharmacology
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yum, S.K. | - |
dc.contributor.author | Yum, S.Y. | - |
dc.contributor.author | Kim, T. | - |
dc.date.accessioned | 2021-09-02T01:21:10Z | - |
dc.date.available | 2021-09-02T01:21:10Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 2289-0882 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/70779 | - |
dc.description.abstract | While hormonal changes during the ovulatory cycles affect multiple body systems, medical management, including medication dosing remains largely uniform between the sexes. Little is known about sex-specific pharmacology in women. Although hormonal fluctuations of the normal menstruating process alters women’s physiology and brain biochemistry, medication dosing does not consider such cyclical changes. Using schizophrenia as an example, this paper illustrates how a woman’s clinical symptoms can change throughout the ovulatory cycle, leading to fluctuations in medication responses. Effects of sex steroids on the brain, clinical pharmacology are discussed. Effective medication dose may be different at different phases of the menstrual cycle. Further research is needed to better understand optimal treatment strategies in reproductive women; we present a potential clinical trial design for examining optimal medication dosing strategies for conditions that have menstruation related clinical fluctuations. © 2019 Tak Kim. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Korean Society Clinical Pharmacology and Therapeutics | - |
dc.subject | estradiol | - |
dc.subject | follitropin | - |
dc.subject | glucose | - |
dc.subject | luteinizing hormone | - |
dc.subject | neuroleptic agent | - |
dc.subject | olanzapine | - |
dc.subject | oral contraceptive agent | - |
dc.subject | perphenazine | - |
dc.subject | progesterone | - |
dc.subject | prolactin | - |
dc.subject | risperidone | - |
dc.subject | testosterone | - |
dc.subject | thyrotropin | - |
dc.subject | venlafaxine | - |
dc.subject | acute disease | - |
dc.subject | adult | - |
dc.subject | amenorrhea | - |
dc.subject | anger | - |
dc.subject | anxiety | - |
dc.subject | Article | - |
dc.subject | auditory hallucination | - |
dc.subject | bleeding | - |
dc.subject | bloating | - |
dc.subject | body mass | - |
dc.subject | breast augmentation | - |
dc.subject | case report | - |
dc.subject | clinical article | - |
dc.subject | clinical evaluation | - |
dc.subject | conceptual disorganization | - |
dc.subject | constipation | - |
dc.subject | delusion | - |
dc.subject | disease duration | - |
dc.subject | disease worsening with drug treatment | - |
dc.subject | evening dosage | - |
dc.subject | female | - |
dc.subject | follow up | - |
dc.subject | human | - |
dc.subject | hyperprolactinemia | - |
dc.subject | menstrual cycle | - |
dc.subject | menstruation | - |
dc.subject | mental disease | - |
dc.subject | mental instability | - |
dc.subject | mood | - |
dc.subject | neuroapoptosis | - |
dc.subject | ovary insufficiency | - |
dc.subject | paranoia | - |
dc.subject | personal hygiene | - |
dc.subject | physical altercation | - |
dc.subject | Positive and Negative Syndrome Scale | - |
dc.subject | psychopharmacology | - |
dc.subject | psychosis | - |
dc.subject | rigidity | - |
dc.subject | schizophrenia | - |
dc.subject | self monitoring | - |
dc.subject | social status | - |
dc.subject | somnolence | - |
dc.subject | tremor | - |
dc.subject | water retention | - |
dc.subject | xerostomia | - |
dc.title | The problem of medicating women like the men: Conceptual discussion of menstrual cycle-dependent psychopharmacology | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, T. | - |
dc.identifier.doi | 10.12793/tcp.2019.27.4.127 | - |
dc.identifier.scopusid | 2-s2.0-85079146219 | - |
dc.identifier.bibliographicCitation | Translational and Clinical Pharmacology, v.27, no.4, pp.127 - 133 | - |
dc.relation.isPartOf | Translational and Clinical Pharmacology | - |
dc.citation.title | Translational and Clinical Pharmacology | - |
dc.citation.volume | 27 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 127 | - |
dc.citation.endPage | 133 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | estradiol | - |
dc.subject.keywordPlus | follitropin | - |
dc.subject.keywordPlus | glucose | - |
dc.subject.keywordPlus | luteinizing hormone | - |
dc.subject.keywordPlus | neuroleptic agent | - |
dc.subject.keywordPlus | olanzapine | - |
dc.subject.keywordPlus | oral contraceptive agent | - |
dc.subject.keywordPlus | perphenazine | - |
dc.subject.keywordPlus | progesterone | - |
dc.subject.keywordPlus | prolactin | - |
dc.subject.keywordPlus | risperidone | - |
dc.subject.keywordPlus | testosterone | - |
dc.subject.keywordPlus | thyrotropin | - |
dc.subject.keywordPlus | venlafaxine | - |
dc.subject.keywordPlus | acute disease | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | amenorrhea | - |
dc.subject.keywordPlus | anger | - |
dc.subject.keywordPlus | anxiety | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | auditory hallucination | - |
dc.subject.keywordPlus | bleeding | - |
dc.subject.keywordPlus | bloating | - |
dc.subject.keywordPlus | body mass | - |
dc.subject.keywordPlus | breast augmentation | - |
dc.subject.keywordPlus | case report | - |
dc.subject.keywordPlus | clinical article | - |
dc.subject.keywordPlus | clinical evaluation | - |
dc.subject.keywordPlus | conceptual disorganization | - |
dc.subject.keywordPlus | constipation | - |
dc.subject.keywordPlus | delusion | - |
dc.subject.keywordPlus | disease duration | - |
dc.subject.keywordPlus | disease worsening with drug treatment | - |
dc.subject.keywordPlus | evening dosage | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | follow up | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | hyperprolactinemia | - |
dc.subject.keywordPlus | menstrual cycle | - |
dc.subject.keywordPlus | menstruation | - |
dc.subject.keywordPlus | mental disease | - |
dc.subject.keywordPlus | mental instability | - |
dc.subject.keywordPlus | mood | - |
dc.subject.keywordPlus | neuroapoptosis | - |
dc.subject.keywordPlus | ovary insufficiency | - |
dc.subject.keywordPlus | paranoia | - |
dc.subject.keywordPlus | personal hygiene | - |
dc.subject.keywordPlus | physical altercation | - |
dc.subject.keywordPlus | Positive and Negative Syndrome Scale | - |
dc.subject.keywordPlus | psychopharmacology | - |
dc.subject.keywordPlus | psychosis | - |
dc.subject.keywordPlus | rigidity | - |
dc.subject.keywordPlus | schizophrenia | - |
dc.subject.keywordPlus | self monitoring | - |
dc.subject.keywordPlus | social status | - |
dc.subject.keywordPlus | somnolence | - |
dc.subject.keywordPlus | tremor | - |
dc.subject.keywordPlus | water retention | - |
dc.subject.keywordPlus | xerostomia | - |
dc.subject.keywordAuthor | Clinical trial design | - |
dc.subject.keywordAuthor | Drug dose | - |
dc.subject.keywordAuthor | Menstrual cycle | - |
dc.subject.keywordAuthor | Schizophrenia | - |
dc.subject.keywordAuthor | Sex steroids | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.